Jonathan Fox
President presso EIDOS THERAPEUTICS, INC.
Patrimonio netto: 198 032 $ in data 31/03/2024
Profilo
Jonathan C. Fox occupa la posizione di presidente e responsabile medico presso Eidos Therapeutics, Inc. Nella sua carriera passata è stato Chief Medical Officer presso MyoKardia, Inc., Senior Director-Clinical Cardiovascular Research presso Merck & Co., Inc., Vice President-Clinical Development presso AstraZeneca LP, Director-Clinical Pharmacology presso GlaxoSmithKline LLC, Clinical Professor presso la University of Pennsylvania, Consultant presso The University of California, San Francisco e Consulting Professor presso Stanford University. Jonathan C. Fox ha conseguito un dottorato e una laurea presso l'Università di Chicago.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
26/12/2023 | 10 857 ( 0.01% ) | 198 032 $ | 31/03/2024 |
Posizioni attive di Jonathan Fox
Società | Posizione | Inizio |
---|---|---|
EIDOS THERAPEUTICS, INC. | President | 01/10/2016 |
EDGEWISE THERAPEUTICS, INC. | Director/Board Member | 02/03/2023 |
BRIDGEBIO PHARMA, INC. | President | - |
ML Bio Solutions, Inc. | Director/Board Member | - |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Director/Board Member | - |
Precedenti posizioni note di Jonathan Fox
Società | Posizione | Fine |
---|---|---|
MYOKARDIA, INC. | Chief Tech/Sci/R&D Officer | 30/09/2016 |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
Stanford University | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Jonathan Fox
The University of Chicago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
EDGEWISE THERAPEUTICS, INC. | Health Technology |
BRIDGEBIO PHARMA, INC. | Health Technology |
Aziende private | 6 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Lankenau Institute for Medical Research
Lankenau Institute for Medical Research BiotechnologyHealth Technology Lankenau Institute for Medical Research operates as a non-profit biomedical research centre. It provides human health and well being through technology development and the training to the next generation of scientists and physicians. The company was founded in 1917 and is headquartered Wynnewood, PA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
ML Bio Solutions, Inc. |
- Borsa valori
- Insiders
- Jonathan Fox